Preliminary results of the initial United States experience with the Supera woven nitinol stent in the popliteal artery Luis R. León, MD, RVT, Robert S. Dieter, MD, RVT, Crystal L. Gadd, MD, Erika Ranellone, PA, Joseph L. Mills, MD, Miguel F. Montero- Baker, MD, Angelika C. Gruessner, PhD, John P. Pacanowski, MD Journal of Vascular Surgery Volume 57, Issue 4, Pages 1014-1022 (April 2013) DOI: 10.1016/j.jvs.2012.10.093 Copyright © 2013 Society for Vascular Surgery Terms and Conditions
Fig 1 Kaplan-Meier curve shows primary patency of the implanted device. Journal of Vascular Surgery 2013 57, 1014-1022DOI: (10.1016/j.jvs.2012.10.093) Copyright © 2013 Society for Vascular Surgery Terms and Conditions
Fig 2 Kaplan-Meier curve shows primary assisted patency of the implanted device. Journal of Vascular Surgery 2013 57, 1014-1022DOI: (10.1016/j.jvs.2012.10.093) Copyright © 2013 Society for Vascular Surgery Terms and Conditions
Fig 3 Kaplan-Meier curve shows secondary patency of the implanted device. Journal of Vascular Surgery 2013 57, 1014-1022DOI: (10.1016/j.jvs.2012.10.093) Copyright © 2013 Society for Vascular Surgery Terms and Conditions
Fig 4 Kaplan-Meier curve shows mortality among the cohort. Journal of Vascular Surgery 2013 57, 1014-1022DOI: (10.1016/j.jvs.2012.10.093) Copyright © 2013 Society for Vascular Surgery Terms and Conditions
Fig 5 Supera Woven Nitinol Stent (IDEV Technologies Inc, Webster, Tex). Journal of Vascular Surgery 2013 57, 1014-1022DOI: (10.1016/j.jvs.2012.10.093) Copyright © 2013 Society for Vascular Surgery Terms and Conditions